Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax

AUTOR(ES)
FONTE

Hematology, Transfusion and Cell Therapy

DATA DE PUBLICAÇÃO

2022

RESUMO

Documentos Relacionados